92855-02-2

Basic information

• Product Name: (E)-1-(4-iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
• Synonyms: (E)-1-(4-iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
• CAS NO: 92855-02-2
• Molecular Weight: 364.183
• Mol File: 92855-02-2.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: (E)-1-(4-iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-1-(4-iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one(92855-02-2)
• EPA Substance Registry System: (E)-1-(4-iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one(92855-02-2)

Safety Data

• Hazardous Substances Data: 92855-02-2(Hazardous Substances Data)

Upstream product

• 13329-40-3 4-Iodoacetophenone 
• 123-11-5 4-methoxy-benzaldehyde 

Downstream Products

• 1350753-42-2 {4-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]phenyl}-3-(methoxyphenyl)prop-2-en-1-one 
• 1350753-41-1 {4-[(E)-2-(4-Hydroxy-3,5-dimethoxyphenyl)ethenyl]phenyl}-3-(4methoxyphenyl)-prop-2-en-1-one 
• 1607465-89-3 (E)-3-(4-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)phenyl)-1-(4-iodophenyl)prop-2-en-1-one 
• 1607465-88-2 (E)-3-(4-(2-(2-hydroxyethoxy)ethoxy)phenyl)-1-(4-iodophenyl)prop-2-en-1-one 
• 1607465-87-1 (E)-3-(4-(2-hydroxyethoxy)phenyl)-1-(4-iodophenyl)prop-2-en-1-one 
• 1607465-90-6 (E)-3-(4-(2-hydroxyethoxy)phenyl)-1-(4-tributylstannylphenyl)prop-2-en-1-one 
• 1028801-20-8 4'-iodo-4-methoxy-chalcone oxime 
• 93315-04-9 3-<4-Iod-benzoyl>-2-<4-methoxy-phenyl>-propionsaeure 
• 93323-11-6 3-<4-Iod-benzoyl>-2-<4-methoxy-phenyl>-propionitril 
• 1021493-94-6 1-(4-iodophenyl)-3-(4-methoxyphenyl)-4-nitrobutan-1-one 

Relevant articles and documents

NARROW ABSORPTION POLYMER NANOPARTICLES AND RELATED METHODS

Polymers, monomers, narrow-band absorbing polymers, narrow-band absorbing monomers, absorbing units, polymer dots, and related methods are provided. Bright, luminescent polymer nanoparticles with narrow-band absorptions are provided. Methods for synthesizing absorbing monomers, methods for synthesizing the polymers, preparation methods for forming the polymer nanoparticles, and applications for using the polymer nanoparticles are also provided.

COMPOSITION FOR TREATING DIABETES AND METABOLIC DISEASES AND A PREPARATION METHOD THEREOF

Disclosed is a chalcone composition for treating diabetes and metabolic syndromes. In particular, the chalcone compound bound with 2-halogen in ring A significantly decreases the blood glucose level in the in vitro anti-diabetic effect experiment. In the in vivo animal model, the leading chalcone compound can prevent the progression of diabetes and control the blood glucose level, and there is no significant difference in the gains in body weight. Throughout the seven-week administration, there are no hepatic or renal toxicity observed.

Stilbene-chalcone hybrids: Design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis

Novel stilbene-chalcone (S-C) hybrids were synthesized via a sequential Claisen-Schmidt-Knoevenagel-Heck approach and evaluated for antiplasmodial activity in in vitro red cell culture using SYBR Green I assay. The most potent hybrid (11) showed IC50